Assessment of proarrhythmogenic risk for chloroquine and hydroxychloroquine using the CiPA concept. Thomet U, Amuzescu B, Knott T, Mann SA, et al. Eur J Pharmacol 2021;913:174632.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Thomet U, Amuzescu B, Knott T, Mann SA, et al. Assessment of proarrhythmogenic risk for chloroquine and hydroxychloroquine using the CiPA concept. Eur J Pharmacol 2021;913:174632.
PMID: 34785211